The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
New perspectives in diabetic neuropathy
Open accessAbstract
Summary Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D), which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy (DPN), the most common microvascular complication, is length-dependent damage to peripheral nerves. DPN pathogenesis is complex, but, at its core, can be viewed as a state of impaired metabolism and bioenergetics failure operating against the backdrop of long peripheral nerve axons supported by glia. This unique peripheral nerve anatomy and the injury consequent to T2D underpins the distal-to-proximal symptomatology of DPN. Earlier work focused on the impact of hyperglycemia on nerve damage and bioenergetics failure, but recent evidence additionally implicates contributions from obesity and dyslipidemia. This review will cover peripheral nerve anatomy, bioenergetics, and glia-axon interactions, building the framework for understanding how hyperglycemia and dyslipidemia induce bioenergetics failure in DPN. DPN and painful DPN still lack disease-modifying therapies, and research on novel mechanism-based approaches are also covered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy
Ślęczkowska, M., Almomani, R., Marchi, M., de Greef, B. T. A., Sopacua, M., Hoeijmakers, J. G. J., Lindsey, P. J., Salvi, E., Bönhof, G. J., Ziegler, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137190 · Cited by 20
Continuum of sensory profiles in diabetes mellitus patients with and without neuropathy and pain
Raputová, J., Rajdová, A., Vollert, J., Šrotová, I., Rebhorn, C., Üçeyler, N., Birklein, F., Sommer, C., Vlčková, E., & Bednařík, J. (2022) · European Journal of Pain · doi:10.1002/ejp.2034 · Cited by 20
Eid, S., Hinder, L. M., Zhang, H., Eksi, R., Nair, V., Eddy, S. F., Eichinger, F. H., Park, M., Saha, J., Berthier, C. C., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002387r · Cited by 19
Self-citationBeirowski, B. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105751 · Cited by 16
Self-citationSystems Biology to Address Unmet Medical Needs in Neurological Disorders
Savelieff, M. G., Noureldein, M. H., & Feldman, E. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2265-0_13 · Cited by 15
Self-citationEid, S., O’Brien, P. D., Hinder, L. M., Hayes, J. M., Mendelson, F. E., Zhang, H., Narayanan, S., Abcouwer, S. F., Brosius, F. C., Pennathur, S., et al. (2021) · Journal of Translational Science · doi:10.15761/jts.1000431 · Cited by 12
Self-citationBabetto, E., & Beirowski, B. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148545 · Cited by 8
Self-citation
Cited by
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
Yang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359255 · Cited by 280
Diabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Metadata
- Authors
- Eid, S. A., Rumora, A. E., Beirowski, B., Bennett, D. L., Hur, J., Savelieff, M. G., & Feldman, E. L.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 111
- Issue
- 17
- Pages
- 2623-2641
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W4378840260
- Cited by
- 257
- References
- 207
- FWCI
- 37.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.